Computed tomography measurement for left atrial appendage closure.
Atrial fibrillation
Computed tomography
Left atrium appendage closure
Left atrium appendage occlusion
Journal
Cardiovascular intervention and therapeutics
ISSN: 1868-4297
Titre abrégé: Cardiovasc Interv Ther
Pays: Japan
ID NLM: 101522043
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
07
03
2022
accepted:
07
03
2022
pubmed:
22
3
2022
medline:
18
6
2022
entrez:
21
3
2022
Statut:
ppublish
Résumé
Percutaneous left atrial appendage closure (LAAC) has been reported many therapeutic effects with regard to its safety and efficacy, and the number of patients with non-valvular atrial fibrillation undergoing LAAC is increasing worldwide. Although it is a highly safe procedure, further improvements are expected and preoperative planning is extremely important. For this purpose, transesophageal echocardiography has been mainly performed so far, however, nowadays, it is recommended to determine a more optimal treatment strategy combined with computed tomography. Preoperative CT predicts not only the risk of the intervention based on anatomical features of the left atrial appendage (LAA) but also the device type and size, sheath type, optimal location for septal puncture and pre-procedurally clarifies the left atrium and LAA dimensions. Furthermore, postoperative CT can evaluate device-related thrombus and peri-device leak, making it possible to observe the postoperative course using less invasive methods. This study reviews the practical utility of CT in pre- and post-LAAC.
Identifiants
pubmed: 35307794
doi: 10.1007/s12928-022-00852-4
pii: 10.1007/s12928-022-00852-4
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
440-449Informations de copyright
© 2022. The Author(s) under exclusive licence to Japanese Association of Cardiovascular Intervention and Therapeutics.
Références
Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005;36:1115–9.
pubmed: 15879330
doi: 10.1161/01.STR.0000166053.83476.4a
Lip GY, Frison L, Halperin JL, Lane DA. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke. 2010;41:2731–8.
pubmed: 20966417
doi: 10.1161/STROKEAHA.110.590257
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67.
pubmed: 17577005
doi: 10.7326/0003-4819-146-12-200706190-00007
Senoo K, Lane DA, Lip GY. Oral anticoagulants for stroke prevention in atrial fibrillation. Curr Probl Cardiol. 2014;39:319–44.
pubmed: 25194766
doi: 10.1016/j.cpcardiol.2014.07.001
Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349:1019–26.
pubmed: 12968085
doi: 10.1056/NEJMoa022913
Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.
pubmed: 21830957
doi: 10.1056/NEJMoa1009638
Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–92.
pubmed: 21870978
doi: 10.1056/NEJMoa1107039
Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093–104.
pubmed: 24251359
doi: 10.1056/NEJMoa1310907
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.
pubmed: 19717844
doi: 10.1056/NEJMoa0905561
Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–9.
pubmed: 8572814
doi: 10.1016/0003-4975(95)00887-X
Reddy VY, Sievert H, Halperin J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312:1988–98.
pubmed: 25399274
doi: 10.1001/jama.2014.15192
Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12.
pubmed: 24998121
doi: 10.1016/j.jacc.2014.04.029
Holmes DR Jr, Doshi SK, Kar S, et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis. J Am Coll Cardiol. 2015;65:2614–23.
pubmed: 26088300
doi: 10.1016/j.jacc.2015.04.025
Osmancik P, Herman D, Neuzil P, et al. 4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation. J Am Coll Cardiol. 2022;79:1–14.
pubmed: 34748929
doi: 10.1016/j.jacc.2021.10.023
Kar S, Doshi SK, Sadhu A, et al. Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial. Circulation. 2021;143:1754–62.
pubmed: 33820423
doi: 10.1161/CIRCULATIONAHA.120.050117
Lakkireddy D, Thaler D, Ellis CR, et al. Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial. Circulation. 2021;144:1543–52.
pubmed: 34459659
pmcid: 8570346
doi: 10.1161/CIRCULATIONAHA.121.057063
Galea R, De-Marco F, Meneveau N, et al. Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial. Circulation. 2021. https://doi.org/10.1161/CIRCULATIONAHA.121.057859 .
doi: 10.1161/CIRCULATIONAHA.121.057859
pubmed: 34747186
So CY, Kang G, Villablanca PA, et al. Additive value of preprocedural computed tomography planning versus stand-alone transesophageal echocardiogram guidance to left atrial appendage occlusion: comparison of real-world practice. J Am Heart Assoc. 2021;10:e020615.
pubmed: 34398676
pmcid: 8649286
doi: 10.1161/JAHA.120.020615
Staab W, Goth S, Sohns C, et al. Comparison of end-diastolic versus end-systolic cardiac-computed tomography reconstruction interval in patient’s prior to pulmonary vein isolation. Springerplus. 2014;3:218.
pubmed: 25279273
pmcid: 4178958
doi: 10.1186/2193-1801-3-218
Patel AR, Fatemi O, Norton PT, et al. Cardiac cycle-dependent left atrial dynamics: implications for catheter ablation of atrial fibrillation. Heart Rhythm. 2008;5:787–93.
pubmed: 18486563
pmcid: 2527027
doi: 10.1016/j.hrthm.2008.03.003
Korsholm K, Berti S, Iriart X, et al. Expert recommendations on cardiac computed tomography for planning transcatheter left atrial appendage occlusion. JACC Cardiovasc Interv. 2020;13:277–92.
pubmed: 31678086
doi: 10.1016/j.jcin.2019.08.054
Budoff MJ, Shittu A, Hacioglu Y, et al. Comparison of transesophageal echocardiography versus computed tomography for detection of left atrial appendage filling defect (thrombus). Am J Cardiol. 2014;113:173–7.
pubmed: 24216123
doi: 10.1016/j.amjcard.2013.09.037
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609–78.
pubmed: 27567465
doi: 10.1093/europace/euw295
Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60:531–8.
pubmed: 22858289
doi: 10.1016/j.jacc.2012.04.032
Naksuk N, Padmanabhan D, Yogeswaran V, Asirvatham SJ. Left atrial appendage: embryology, anatomy, physiology, arrhythmia and therapeutic intervention. JACC Clin Electrophysiol. 2016;2:403–12.
pubmed: 29759858
doi: 10.1016/j.jacep.2016.06.006
Korhonen M, Muuronen A, Arponen O, et al. Left atrial appendage morphology in patients with suspected cardiogenic stroke without known atrial fibrillation. PLoS ONE. 2015;10:e0118822.
pubmed: 25751618
pmcid: 4353716
doi: 10.1371/journal.pone.0118822
Korhonen M, Parkkonen J, Hedman M, et al. Morphological features of the left atrial appendage in consecutive coronary computed tomography angiography patients with and without atrial fibrillation. PLoS ONE. 2017;12:e0173703.
pubmed: 28288200
pmcid: 5348027
doi: 10.1371/journal.pone.0173703
Yu CM, Khattab AA, Bertog SC, et al. Mechanical antithrombotic intervention by LAA occlusion in atrial fibrillation. Nat Rev Cardiol. 2013;10:707–22.
pubmed: 24145892
doi: 10.1038/nrcardio.2013.158
Hosoda N, Asami M, Tanaka J, Usui T, Tanabe K. Usefulness of preprocedural dedicated computed tomography for complex case in percutaneous left atrial appendage closure. Cardiovasc Interv Ther. 2021;36:559–61.
pubmed: 32918248
doi: 10.1007/s12928-020-00706-x
Rajwani A, Nelson AJ, Shirazi MG, et al. CT sizing for left atrial appendage closure is associated with favourable outcomes for procedural safety. Eur Heart J Cardiovasc Imaging. 2017;18:1361–8.
pubmed: 28013284
doi: 10.1093/ehjci/jew212
Wang DD, Eng M, Kupsky D, et al. Application of 3-Dimensional computed tomographic image guidance to WATCHMAN implantation and impact on early operator learning curve: single-center experience. JACC Cardiovasc Interv. 2016;9:2329–40.
pubmed: 27884358
doi: 10.1016/j.jcin.2016.07.038
Wang K, Duan CY, Wu J, et al. Predictive value of neutrophil gelatinase-associated lipocalin for contrast-induced acute kidney injury after cardiac catheterization: a meta-analysis. Can J Cardiol. 2016;32(1033):e19-29.
Hołda MK, Koziej M, Wszołek K, et al. Left atrial accessory appendages, diverticula, and left-sided septal pouch in multi-slice computed tomography. Association with atrial fibrillation and cerebrovascular accidents. Int J Cardiol. 2017;244:163–8.
pubmed: 28629626
doi: 10.1016/j.ijcard.2017.06.042
Abbara S, Mundo-Sagardia JA, Hoffmann U, Cury RC. Cardiac CT assessment of left atrial accessory appendages and diverticula. AJR Am J Roentgenol. 2009;193:807–12.
pubmed: 19696296
doi: 10.2214/AJR.08.2229
Troupis J, Crossett M, Scneider-Kolsky M, Nandurkar D. Presence of accessory left atrial appendage/diverticula in a population with atrial fibrillation compared with those in sinus rhythm: a retrospective review. Int J Cardiovasc Imaging. 2012;28:375–80.
pubmed: 21331611
doi: 10.1007/s10554-011-9815-4
Wan Y, He Z, Zhang L, et al. The anatomical study of left atrium diverticulum by multi-detector row CT. Surg Radiol Anat. 2009;31:191–8.
pubmed: 18923806
doi: 10.1007/s00276-008-0427-1
Şeker M. The characteristics of left atrial diverticula in normal sinüs rhythm patients. Surg Radiol Anat. 2020;42:377–84.
pubmed: 31768699
doi: 10.1007/s00276-019-02382-w
Sanfilippo AJ, Abascal VM, Sheehan M, et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation. 1990;82:792–7.
pubmed: 2144217
doi: 10.1161/01.CIR.82.3.792
Barbier P, Alioto G, Guazzi MD. Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1994;24:165–70.
pubmed: 8006261
doi: 10.1016/0735-1097(94)90558-4
Dittrich HC, Pearce LA, Asinger RW, et al. Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J. 1999;137:494–9.
pubmed: 10047632
doi: 10.1016/S0002-8703(99)70498-9
Nakamura K, Funabashi N, Uehara M, et al. Left atrial wall thickness in paroxysmal atrial fibrillation by multislice-CT is initial marker of structural remodeling and predictor of transition from paroxysmal to chronic form. Int J Cardiol. 2011;148:139–47.
pubmed: 19906452
doi: 10.1016/j.ijcard.2009.10.032
Behnes M, Akin I, Sartorius B, et al. –LAA Occluder View for post-implantation Evaluation (LOVE)–standardized imaging proposal evaluating implanted left atrial appendage occlusion devices by cardiac computed tomography. BMC Med Imaging. 2016;16:25.
pubmed: 27009279
pmcid: 4806427
doi: 10.1186/s12880-016-0127-y
Kaafarani M, Saw J, Daniels M, et al. Role of CT imaging in left atrial appendage occlusion for the WATCHMAN™ device. Cardiovasc Diagn Ther. 2020;10:45–58.
pubmed: 32175227
pmcid: 7044092
doi: 10.21037/cdt.2019.12.01
Qamar SR, Jalal S, Nicolaou S, Tsang M, Gilhofer T, Saw J. Comparison of cardiac computed tomography angiography and transoesophageal echocardiography for device surveillance after left atrial appendage closure. EuroIntervention. 2019;15:663–70.
pubmed: 31217149
doi: 10.4244/EIJ-D-18-01107
Saw J, Fahmy P, DeJong P, et al. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure. Eur Heart J Cardiovasc Imaging. 2015;16:1198–206.
pubmed: 25851318
pmcid: 4609159
doi: 10.1093/ehjci/jev067
Dukkipati SR, Kar S, Holmes DR, et al. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation. 2018;138:874–85.
pubmed: 29752398
doi: 10.1161/CIRCULATIONAHA.118.035090
Fauchier L, Cinaud A, Brigadeau F, et al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol. 2018;71:1528–36.
pubmed: 29622159
doi: 10.1016/j.jacc.2018.01.076
Simard T, Jung RG, Lehenbauer K, et al. Predictors of device-related thrombus following percutaneous left atrial appendage occlusion. J Am Coll Cardiol. 2021;78:297–313.
pubmed: 34294267
doi: 10.1016/j.jacc.2021.04.098
Sedaghat A, Vij V, Al-Kassou B, et al. Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-registry. Circ Cardiovasc Interv. 2021;14:e010195.
pubmed: 34003661
doi: 10.1161/CIRCINTERVENTIONS.120.010195
Banga S, Osman M, Sengupta PP, et al. CT assessment of the left atrial appendage post-transcatheter occlusion—a systematic review and meta analysis. J Cardiovasc Comput Tomogr. 2021;15:348–55.
pubmed: 33384253
doi: 10.1016/j.jcct.2020.12.003
Zhao MZ, Chi RM, Yu Y, et al. Value of detecting peri-device leak and incomplete endothelialization by cardiac CT angiography in atrial fibrillation patients post Watchman LAAC combined with radiofrequency ablation. J Cardiovasc Electrophysiol. 2021;32:2655–64.
pubmed: 34428342
doi: 10.1111/jce.15222
Korsholm K, Jensen JM, Nielsen-Kudsk JE. Cardiac computed tomography for left atrial appendage occlusion: acquisition, analysis, advantages, and limitations. Interv Cardiol Clin. 2018;7:229–42.
pubmed: 29526291
Yamamoto M, Adachi Y, Tsunaki T, Suzuki T. Newly developed collateral artery inside a left appendage closure device. JACC Cardiovasc Interv. 2021;14:2744–5.
pubmed: 34538598
doi: 10.1016/j.jcin.2021.08.008
Murtaza G, Murtaza KT, Dar T, et al. Left atrial appendage occlusion device embolization (the Laaode study): understanding the timing and clinical consequences from a worldwide experience. J Atr Fibrillation. 2021;13:2516.
pubmed: 34950344
pmcid: 8691350
doi: 10.4022/jafib.2516